Repurposing the antioxidant and anti-inflammatory agent N-acetyl cysteine for treating COVID-19

Although several considerations have been raised suggesting a beneficial effect of N-acetyl cysteine (NAC) for the treatment of severe acute respiratory syndrome coronavirus 2 infection, there is currently no clinical evidence that NAC truly prevents coronavirus disease 2019 (COVID-19), reduces the...

Descripción completa

Detalles Bibliográficos
Autores principales: Finsterer, Josef, Scorza, Fulvio A, Scorza, Carla A, Fiorini, Ana C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788215/
https://www.ncbi.nlm.nih.gov/pubmed/35117973
http://dx.doi.org/10.5501/wjv.v11.i1.82
_version_ 1784639511812112384
author Finsterer, Josef
Scorza, Fulvio A
Scorza, Carla A
Fiorini, Ana C
author_facet Finsterer, Josef
Scorza, Fulvio A
Scorza, Carla A
Fiorini, Ana C
author_sort Finsterer, Josef
collection PubMed
description Although several considerations have been raised suggesting a beneficial effect of N-acetyl cysteine (NAC) for the treatment of severe acute respiratory syndrome coronavirus 2 infection, there is currently no clinical evidence that NAC truly prevents coronavirus disease 2019 (COVID-19), reduces the severity of the disease, or improves the outcome. Appropriately designed clinical trials are warranted to prove or disprove a therapeutic effect of NAC for COVID-19 patients.
format Online
Article
Text
id pubmed-8788215
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-87882152022-02-02 Repurposing the antioxidant and anti-inflammatory agent N-acetyl cysteine for treating COVID-19 Finsterer, Josef Scorza, Fulvio A Scorza, Carla A Fiorini, Ana C World J Virol Letter to the Editor Although several considerations have been raised suggesting a beneficial effect of N-acetyl cysteine (NAC) for the treatment of severe acute respiratory syndrome coronavirus 2 infection, there is currently no clinical evidence that NAC truly prevents coronavirus disease 2019 (COVID-19), reduces the severity of the disease, or improves the outcome. Appropriately designed clinical trials are warranted to prove or disprove a therapeutic effect of NAC for COVID-19 patients. Baishideng Publishing Group Inc 2022-01-25 2022-01-25 /pmc/articles/PMC8788215/ /pubmed/35117973 http://dx.doi.org/10.5501/wjv.v11.i1.82 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Letter to the Editor
Finsterer, Josef
Scorza, Fulvio A
Scorza, Carla A
Fiorini, Ana C
Repurposing the antioxidant and anti-inflammatory agent N-acetyl cysteine for treating COVID-19
title Repurposing the antioxidant and anti-inflammatory agent N-acetyl cysteine for treating COVID-19
title_full Repurposing the antioxidant and anti-inflammatory agent N-acetyl cysteine for treating COVID-19
title_fullStr Repurposing the antioxidant and anti-inflammatory agent N-acetyl cysteine for treating COVID-19
title_full_unstemmed Repurposing the antioxidant and anti-inflammatory agent N-acetyl cysteine for treating COVID-19
title_short Repurposing the antioxidant and anti-inflammatory agent N-acetyl cysteine for treating COVID-19
title_sort repurposing the antioxidant and anti-inflammatory agent n-acetyl cysteine for treating covid-19
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8788215/
https://www.ncbi.nlm.nih.gov/pubmed/35117973
http://dx.doi.org/10.5501/wjv.v11.i1.82
work_keys_str_mv AT finstererjosef repurposingtheantioxidantandantiinflammatoryagentnacetylcysteinefortreatingcovid19
AT scorzafulvioa repurposingtheantioxidantandantiinflammatoryagentnacetylcysteinefortreatingcovid19
AT scorzacarlaa repurposingtheantioxidantandantiinflammatoryagentnacetylcysteinefortreatingcovid19
AT fiorinianac repurposingtheantioxidantandantiinflammatoryagentnacetylcysteinefortreatingcovid19

Ejemplares similares